MSB 1.56% 97.5¢ mesoblast limited

FTC opens investigation into Teva, escalating patent fight with...

  1. 431 Posts.
    lightbulb Created with Sketch. 93
    FTC opens investigation into Teva, escalating patent fight with pharma industry

    Democrats have accused drug companies of “junk patent listings,” arguing that the industry is blocking generic competition and inflating patients’ costs.

    http://washingtonpost.com/health/2024/07/01/teva-patent-pharma-generic-inhaler/?gaa_at=la&gaa_n=ARTJ-U9wgnTOF-ZrRCe90ocA0__CS0I8bt1E4w3-Ti935uhPTPKWP6vTra0XDqHHd3s%3D&gaa_
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.5¢
Change
0.015(1.56%)
Mkt cap ! $1.113B
Open High Low Value Volume
97.0¢ 99.5¢ 97.0¢ $2.315M 2.360M

Buyers (Bids)

No. Vol. Price($)
9 119971 97.5¢
 

Sellers (Offers)

Price($) Vol. No.
99.0¢ 24889 9
View Market Depth
Last trade - 16.10pm 22/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.